Meanwhile, low expression levels of TBRII have been observed in chronic myeloid leukemia and colon cancer patients, and mutations in TBRII are frequently found in colon cancer, gastric cancer, ovarian cancer, and nonsmall cell lung carcinoma [22]. Here, TGFBR2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.